Team | Meet ACI Biosciences catharine November 21, 2024

Our name is now ACI Biosciences, reflecting our history as ACI and our expanded service offering.

ACI Biosciences has evolved from the conduct of clinical trials in specialty veterinary medicine to become a provider of comprehensive product development services. We work for the animal health industry, with veterinarians and pet owners, scientists and subject matter experts, to develop novel products for animals with complex medical conditions.

History of ACI Biosciences

October 2000

Organized as a Maryland LLC; created the ACI Network of Investigators

October 2000
2001 - 2008

Focused on early-stage, clinical field studies in veterinary oncology and internal medicine

2001 - 2008
2008 - 2011

First pivotal field effectiveness study, regulatory support, additional studies in specialty medicine

2008 - 2011
2011 - 2017

Additional studies in translational medicine, dermatology, cardiology, pain management, regenerative medicine

2011 - 2017
2017 - 2023

Evolution to a true product development platform with depth of expertise

2017 - 2023
2023

ACI announces its evolution to ACI Biosciences

2023
2024

ACI Biosciences Brasil is set to launch

2024

History of ACI Biosciences

October 2000

Organized as a Maryland LLC; created the ACI Network of Investigators

October 2000
2001 - 2008

Focused on early-stage, clinical field studies in veterinary oncology and internal medicine

2001 - 2008
2008 - 2011

First pivotal field effectiveness study, regulatory support, additional studies in specialty medicine

2008 - 2011
2011 - 2017

Additional studies in translational medicine, dermatology, cardiology, pain management, regenerative medicine

2011 - 2017
2017 - 2023

Evolution to a true product development platform with depth of expertise

2017 - 2023
2023

ACI announces its evolution to ACI Biosciences

2023
2024

ACI Biosciences Brasil is set to launch

2024

Leadership Team

Kristen Khanna, PhD, MBA
Chief Executive Officer
Eden Bermingham, DVM, MS, DACVPT
Executive Director of Pharmacology and Drug Development
Philippe Brianceau, DVM
Chief Development Officer and President of ACI Biosciences Brasil
Renee Frey, MBA
Senior Director of Quality Assurance
Carl Johnson, AM, DVM
Chief Strategy Officer
Beth Kee, DVM
Senior Director of Clinical Development and Study Operations
Terri Wasmoen, PhD
Executive Director of Biologics Product Development

CMC Team

Niki Waldron
Formulation Development / Project Management
Mark Steele
Regulatory Affairs, Formulation, and Manufacturing
Tiffany Prentice, PhD
Analytical Chemistry Development
Tom Mulhern, PhD
Drug Substance Process Development
John Masengale
Quality Control (QC) / Quality Assurance (QA)
Let's work together

Teamwork is the ability to work together toward a common vision

We are one team and therefore enjoy, and work hard to maintain, a cooperative, all-hands work environment.

Staff

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Michelle Bradford, MS
Clinical Development Manager
Alvaro Cisternas, BVSc, DVM
Product Development Director
Christine Costello
Data Manager
Carrie Emke, RVT, MS
Study Monitor
Marissa Farbo, BS
Clinical Development Manager
Beth Fults, RVT, VTS (ECC, SAIM)
Study Monitor
Stacy Hall
Controller
Michelle Jasukonis, BS, CVT
Study Monitor
Kate Jennen
Biologics Clinical Development Manager
Regina Jensen, DVM
Clinical Development Manager
Tanji Lewis
Study Monitor
JT Means, MS
Data Manager
Stephanie Pierce, DVM, DACVIM (SAIM)
Director of Clinical Development
Brittany Ronan, CVT, MS
Study Monitor
Judy Rosales
Clinical Operations Manager
Tony Rusk, DVM
Medical Advisor
Shelly Zacharias, DVM, MS, VPM
Clinical Development Manager

Curious about joining the Team?

Schedule a call, and we’ll answer your questions and discuss next steps.